Exhibit 10(c)


                          Management Incentive Plan 2004

The Incentive Bonus Plan for 2004 is based on the following concepts:

*   As a participant in the Management Incentive Plan your contribution impacts
    overall corporate performance.  To reflect this, all participants will have
    Corporate Earnings Per Share as a performance factor.

*   Division and Region Performance will focus on the achievement of key
    business fundamentals:  Net Sales (Revenue), Operating Profit and prudent
    cash management as measured by Free Cash Flow from Operations.

Here's how the plan works:

TARGET BONUS

The target bonus opportunity is a specific percentage of a participant's base
salary (as of December 31 of the plan year) and represents the amount of bonus a
participant could receive if 100% of all performance factors were achieved.

INDIVIDUAL PERFORMANCE

For 2004, managers have the discretion to increase a participant's incentive
award up to 25% for superior performance, reduce the award as performance
warrants or if performance is unsatisfactory, eliminate the award.

PERFORMANCE-PAYOUT RELATIONSHIP

A performance payout matrix has been established to determine the relationship
between performance against an established plan target and the incentive award
earned.  The matrix sets a threshold of minimum performance at 85% for all
performance factors with a commensurate payout of 50%.  If less than 85% of
the plan targeted performance is achieved, there will be no incentive paid.
Achieving plan targets results in a 100% incentive earned for that performance
factor.  A maximum payout of 150% has been established for each performance
factor.  The maximum performance required to achieve 150% payout will vary
depending on the performance factor.  Most factors reach the maximum levels at
115% of plan; others will require 150% achievement of plan.

Performance factors are independent of one another for incentive calculation
purposes.  A participant's final incentive calculation will be based on the
sum of all factors for his/her particular plan (region, division, corporate,
etc.), adjusted for individual performance.


INCENTIVE POOL

For each incentive plan an incentive pool will be established.

The total of all incentive awards cannot exceed the total pool of incentive
funds for that particular incentive plan.


BONUS PAYOUTS

Beginning in 2004, a participant will have the option of participating in the
stock bonus program.  In other words, he/she may elect to receive his/her
entire post-tax award in cash or take any percentage between 25% and 100% of his/her
post-tax incentive award in shares of West Pharmaceutical Services common
stock.

These shares will be deposited with an investment firm where accounts are
maintained for our Stock Bonus Plan.  We encourage participants to retain
these shares and to take advantage of the incentive share opportunities of the
Stock Bonus Plan.

STOCK BONUS PLAN

Here are the highlights of the Stock Bonus Plan:

   *  At least 25% of a participant's after-tax annual bonus can be paid in
      shares of West Pharmaceutical Services common stock ("bonus shares").
      However, a participant may elect to have up to 100% of his/her bonus paid
      in shares.

   *  Participants may elect to commit bonus shares to long-term holding by
      depositing those shares into an authorized account.  Shares will be held
      in the participant's name.

   *  If a participant commits to long-term holding, a number of restricted
      shares ("incentive shares") equal to 25% of the committed bonus shares
      will be issued to the participant.

   *  The incentive shares will contain a legend stipulating that the restrictions
      lapse at the end of four years from the date of issuance, as long as
      the bonus shares are continuously held by the participant during that
      four-year period.

   *  If a participant retires under a West Pharmaceutical sanctioned Retirement
      Plan, the restrictions will lapse, as long as the bonus shares have been
      retained continuously.  Participants will be entitled to receive a portion
      of the Incentive Shares according to the following schedule:

      25% with at least one but less than two years continuous ownership of
      the bonus shares.

      50% with at least two but less than three years continuous ownership
      of the bonus shares.

      75% with at least three but less than four years continuous ownership
      of the bonus shares.

   *  Participants will receive dividends from bonus shares and restricted
      shares as they are declared.  These dividends will be reinvested in
      stock of West Pharmaceutical Services.

   *  Ownership records will be reviewed annually to verify continuous
      ownership.

ELIGIBILITY

Eligibility and the amount and type of awards under this plan are solely at the
discretion of management and are not guaranteed under any circumstances.
Participants must be active employees on December 31 of the plan year to be
eligible for bonus payment consideration.  Awards will be prorated based on
eligibility date.

PERFORMANCE FACTOR DEFINITIONS

Earnings Per Share (EPS): Determined by dividing the corporation's after tax
net income, adjusted for foreign exchange at budgeted rates and special items,
by the average number of shares of stock of outstanding.

Special Adjustments:  Those items that are material, unusual in nature and/or
occur infrequently.  Special adjustments are subject to Board Compensation
Committee review and acceptance.

Net Sales: The revenue generated by the sale of products or services less
returns and allowances.

Operating Profit: Net sales (as defined above) minus the cost of goods sold,
lab and engineering expense, selling, general, administrative and other
expense.

Division Cash Flow from Operations:  Operating profit plus depreciation
adjusted for increases or decreases in accounts receivable, inventory and
accounts payable minus capital expenditures.

Corporate Cash Flow: Cash flow from operations minus capital expenditures,
dividends and special adjustments.

Note:  For incentive plan purposes, Earnings Per Share, Net Sales, Operating
Profit and Cash Flow Factors from non-U.S. operations will be measured at
budgeted exchange rates.

Following are the 2004 performance factors each weighted as to its influence on
the overall bonus calculation.  The Management Incentive Bonus Plan's
performance factors vary per division within the Company.

CORPORATE PERFORMANCE FACTORS

  * Corporate financial performance:
    Corporate performance will be measured on the achievement of the Company's
    2004 Earnings Per Share and Cash Flow targets:
        - EPS: [65%]
        - Corporate Cash Flow: [35%]

PHARMACEUTICAL SYSTEMS DIVISION PERFORMANCE FACTORS

  * Division financial performance (75%)
    2004 key financial performance factors:
        - Net Sales [25%]
        - Operating Profit [50%]
        - Division Free Cash Flow [25%]

  * Corporate Financial Performance (25%): Corporate performance will be
    measured on the achievement of the Company's 2004 Earnings Per Share target.

PHARMACEUTICAL SYSTEMS DIVISON'S REGIONS (AMERICAS, EURASIA and DEVICE GROUP
REGIONS) PERFORMANCE FACTORS

  * Region performance (50%): A significant portion of a participant's bonus
    opportunity
     will hinge on his/her region's achievement of the operating profit and net
     sales (revenue) goal contained in the annual business plan.
        - Net Sales [25%]
        - Operating Profit [75%]

  * Division financial performance (25%):  Division performance will be
    measured on achievement of these financial goals in the division's annual
    business plan:
        - Net Sales [25%]
        - Operating Profit [50%]
        - Division Free Cash Flow [25%]

  * Corporate Financial Performance (25%): Corporate performance will be
    measured on the achievement of the Company's 2004 Earnings Per Share target.

DRUG DELIVERY DIVISION PERFORMANCE FACTORS

  * Division financial performance and strategic objectives (75%)
    2004 key financial performance factors:
        - Operating Profit [40%]

    2004 key strategic objectives:
        - Advance 3 products into Phase II Trials [30%]
        - Sign 3 licensing and/or development agreements [30%]

  * Corporate Financial Performance (25%): Corporate performance will be
    measured on the achie